NFE2L2 and diabetes mellitus: Collectively, this study proposes pharmacological Nrf2 activation as a useful therapeutic strategy to restrain diabetes-driven atherosclerosis, by attenuating oxidative stress and inflammation, and bolstering antioxidant defense and autophagy.